Stentrode brain computer interface online in first two human patients

Publication/Creation Date
October 28 2020
Synchron Inc. (creator)
Thomas Oxley (creator)
Royal Melbourne Hospital (contributor)
Gil Rind (contributor)
Peter Yoo (contributor)
Nicholas Opie (contributor)
Food And Drug Administration (FDA) (contributor)
Society Of NeuroInterventional Surgery (SNIS) (contributor)
Media Type
Corporate Video
Persuasive Intent
Discursive Type
"Synchron, a neurovascular bioelectronics medicine company, today announced publication of a first-in-human study demonstrating successful use of the Stentrode™ brain-computer interface (BCI), or neuroprosthesis. Specifically, the study shows the Stentrode’s ability to enable patients with severe paralysis to resume daily tasks, including texting, emailing, shopping and banking online, through direct thought, and without the need for open brain surgery. The study is the first to demonstrate that a BCI implanted via the patient’s blood vessels is able to restore the transmission of brain impulses out of the body, and did so wirelessly. The patients were able to use their impulses to control digital devices without the need for a touchscreen, mouse, keyboard or voice activation technology. This feasibility study was published in the Journal of NeuroInterventional Surgery (JNIS), the leading international peer-review journal for the clinical field of neurointerventional surgery, and official journal of the Society of NeuroInterventional Surgery (SNIS)."

The device is described as a "brain bluetooth".
HCI Platform
Relation to Body
Related Body Part
Brain, Chest